Fundraising Fox
/Companies
Sign in

Genoskin

11 known investors

Find your way into Genoskin

Sign up to see every warm intro you have to Genoskin

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Genoskin team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Genoskin offers MANTIS, a spatial biology platform that performs multiplex 3D imaging analysis of human skin tissue to study immune cell responses to vaccines, drugs, and cosmetics. The platform enables automated, unbiased profiling of immune cells within their tissue context using fluorescence-based imaging and proprietary computational analysis.

BiotechDeep TechMedical Devices

Founders & leadership

PDPascal Descargues, PhD
Pascal Descargues, PhDFounder and CEOPascal Descargues holds a PhD in Human Pathophysiology from the University of Toulouse and a Master's in Management from Toulouse Business School. He founded Genoskin in 2011, which develops living human skin models and spatial biology platforms for drug development and safety assessment.

Investors · 11

BNP Paribasreported

How we know: genoskin.com · Not right? Tell us

BpifrancereportedParis, Ile-De-France · $270K

How we know: genoskin.com · Not right? Tell us

OCCTEreported

How we know: funding news · tech.eu · Not right? Tell us

Also in the syndicate · 7

CA Toulouse 31 InitiativesCA Toulouse 31 Initiatives (CAT31i)Caisse d’EpargneCaisse d’Epargne Midi-PyrénéesCaptech SantéCrédit AgricoleGSO Innovation

Funding

SEC filings, press & company announcements

$8.7M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

PRESS RELEASE - Genoskin appoints new board member to strengthen governance - Genoskingenoskin.com · Apr 2026Genoskin, a Toulouse, France-based Contract Research Organization (CRO) to develop ex vivo human skin platforms, raised $8.7M in Series A funding.finsmes.com · Sep 2025Genoskin raises series A to advance human-based drug development - Genoskingenoskin.com · Sep 2025

Frequently asked questions

What does Genoskin do?
Genoskin offers MANTIS, a spatial biology platform that performs multiplex 3D imaging analysis of human skin tissue to study immune cell responses to vaccines, drugs, and cosmetics. The platform enables automated, unbiased profiling of immune cells within their tissue context using fluorescence-based imaging and proprietary computational analysis.
Who founded Genoskin?
Genoskin was founded by Pascal Descargues, PhD.
Who are Genoskin's investors?
Genoskin's investors include Grand Sud Ouest Capital, BNP Paribas, Bpifrance, OCCTE.
How much funding has Genoskin raised?
Genoskin has disclosed $8.7M raised across 1 of its 2 known rounds.